Using a risk assessment score that incorporates CA 125 values, prealbumin, and menopausal status may help predict which women presenting with a pelvic mass are most likely to have ovarian cancer, according to this prize-winning paper presented at the 2006 ACOG clinical meeting in Washington, D.C.
Using a risk assessment score that incorporates CA 125 values, prealbumin, and menopausal status may help predict which women presenting with a pelvic mass are most likely to have ovarian cancer, according to this prize-winning paper presented at the 2006 ACOG clinical meeting in Washington, D.C. When investigators from St. Vincent Women's Hospital in Indianapolis used these three parameters to determine preoperative risk in 130 women, 129 of whom subsequently underwent a laparotomy, an ovarian cancer risk assessment (OCRA) score of 200 or greater yielded a sensitivity of 100%, specificity of 83%, and positive predictive value of 78% for detecting ovarian cancer. In the words of the researchers: "[OCRA] can be easily applied clinically and may help facilitate appropriate referral of women to gynecologic oncologists..."
Ronco DA, Geisler JP, Manahan KJ. Ovarian cancer risk assessment: A tool for preoperative prediction of ovarian cancer in women with pelvic masses. Obstet Gynecol. 2006;107 (4 suppl):11S.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More